Cipla informs about credit rating

16 May 2017 Evaluate

Cipla has informed that Credit Analysis and Research (CARE) has reaffirmed a CARE A1+ rating to the various existing short-term bank facilities. The Company is not availing long-term bank facilities and accordingly the rating for long-term bank facilities has been withdrawn.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1397.95 -36.65 (-2.55%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×